🔗 Share this article

An underground economy for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Online

Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.

Several experts stated the demand for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking fines, legal action or imprisonment.

Platform Reaction and Material Removal

Based on TikTok, the service has removed problematic material and banned related hashtags and query recommendations. The company said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of users, populated with images of slimming results, glowing testimonials and detailed guides for mixing or administering at home.

After moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.

Product Information and Pricing

Within these communities, posts show dark colored parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service said it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they cannot confirm. Although the research behind retatrutide is valid, these online products may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has already encountered patients injured by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to possibly significant medical dangers”.